SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-013156
Filing Date
2020-02-10
Accepted
2020-02-10 12:01:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207001d3_sc13ga.htm SC 13G/A 54754
  Complete submission text file 0001104659-20-013156.txt   56270
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 20590498
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606
Business Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606 312-236-1600
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by) CIK: 0001644956 (see all company filings)

IRS No.: 472614791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A